Elanco Animal Health (ELAN) Non Operating Income (2017 - 2024)
Elanco Animal Health's (ELAN) quarterly Non Operating Income came in at -$1.0 million in Q3 2024, up 88.89% year-on-year from -$529411.8 in Q4 2023, and up 50.0% quarter-over-quarter from -$2.0 million in Q2 2024.
Elanco Animal Health (ELAN) Non Operating Income (2017 - 2024) Analysis & Trends
Elanco Animal Health has disclosed Non Operating Income across 8 years of filings, most recently posting -$1.0 million for Q3 2024.
- Non Operating Income for Q3 2024 came in at -$1.0 million, up 88.89% year-over-year; the trailing twelve-month figure through Sep 2024 was -$46.0 million (up 25.81% YoY), and the FY2023 annual result was -$75.0 million, down 134.38% from the prior year.
- Non Operating Income came in at -$1.0 million for Q3 2024 at Elanco Animal Health, up from -$2.0 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $115.0 million in Q3 2020 to a low of -$34.0 million in Q4 2023.
- The 5-year median for Non Operating Income is -$5.0 million (2022), against an average of $3.0 million.
- Across the five-year window, Non Operating Income jumped 1330.77% in 2020 and tumbled 800.0% in 2022, its largest moves.
- Elanco Animal Health's Non Operating Income stood at $16.0 million in 2020, then plunged by 81.25% to $3.0 million in 2021, then sank by 800.0% to -$21.0 million in 2022, then plunged by 61.9% to -$34.0 million in 2023, then soared by 97.06% to -$1.0 million in 2024.
- The last three Non Operating Income figures came in at -$1.0 million (Q3 2024), -$2.0 million (Q2 2024), and -$9.0 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | -4.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -9.00 Mn |
| Dec 31, 2023 | -34.00 Mn |
| Sep 30, 2023 | -9.00 Mn |
| Jun 30, 2023 | -23.00 Mn |
| Mar 31, 2023 | -9.00 Mn |
| Dec 31, 2022 | -21.00 Mn |
| Sep 30, 2022 | -8.00 Mn |
| Jun 30, 2022 | 6.00 Mn |
| Mar 31, 2022 | -9.00 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | -11.00 Mn |
| Jun 30, 2021 | 3.00 Mn |
| Dec 31, 2020 | 16.00 Mn |
| Sep 30, 2020 | 115.00 Mn |
| Jun 30, 2020 | 48.00 Mn |
| Mar 31, 2020 | -1.00 Mn |
| Dec 31, 2019 | -6.90 Mn |
| Sep 30, 2019 | -14.60 Mn |